Zentek Ltd

Análisis de la acción Zentek Ltd (ZTEK)

$0.492

-0.025 (-5.02%)Al cierre

Loading chart…
Máximo
0.556
Apertura
0.483
Precio medio ponderado por volumen
0.50
Volumen
944.63K
Capitalización
102.78M
Mínimo
0.450
Importe
471.65K
EV/EBITDA, TTM
0.00

Zentek Ltd. is an intellectual property technology company. The Company is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The Company is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The Company has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The Company is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.

www.zentek.com

Análisis de IA of Zentek Ltd (ZTEK)

Vender

Zentek Ltd is not a good buy right now due to its very low RSI of 17.813, indicating it is oversold, and a significant decline of 40.19% over the past year. The company is facing ongoing financial losses, with a net income loss of -3,526,268 CAD in the latest quarter, which raises concerns about its financial health.

Métricas de valoración

El PER previsto actual de Zentek Ltd (ZTEK) es 0.00, frente a su media de 5 años de -16.99.

PER previsto

Sobrevalorado
Media 5A P/E
-16.99
P/E actual
0.00
Sobrevalorada
-7.30
Infravalorada
-26.67

EV/EBITDA previsto

Muy infravalorado
Media 5A EV/EBITDA
0.00
EV/EBITDA actual
0.00
Sobrevalorada
0.00
Infravalorada
0.00

Precio/ventas previsto

Valor razonable
Media 5A P/S
44.91
P/S actual
0.00
Sobrevalorada
145.65
Infravalorada
-55.83

Cronología de eventos

2026-05-06 (ET)

11:50:00

Zentek Ltd. Stock Trading Halted, News Pending

2026-03-25 (ET)

08:50:00

Zentek's Subsidiary Triera to Offer CRO Services

2026-03-13 (ET)

08:40:00

Zentek Court Dismisses Eveleigh's Over $6 Million Claims

2026-03-04 (ET)

08:30:00

Zentek Initiates Evaluation Program with Quality Filters

2026-01-05 (ET)

09:40:00

Zentek's Subsidiary Albany Graphite Meets Standards for High-Return Markets

Noticias

Preguntas frecuentes sobre ZTEK, respondidas por Alphio AI

Zentek Ltd. is an intellectual property technology company. The Company is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The Company is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The Company has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The Company is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials. It operates in the Healthcare sector.

Zentek Ltd is not a good buy right now due to its very low RSI of 17.813, indicating it is oversold, and a significant decline of 40.19% over the past year. The company is facing ongoing financial losses, with a net income loss of -3,526,268 CAD in the latest quarter, which raises concerns about its financial health.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar